These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Predictive value of Banff score of early kidney allograft biopsies for 1-year graft survival. Kaminska D; Bernat B; Mazanowska O; Krasnowski R; Polak W; Patrzalek D; Kochman A; Klinger M Transplant Proc; 2006; 38(1):59-61. PubMed ID: 16504664 [TBL] [Abstract][Full Text] [Related]
29. Eighteen-year follow-up of a retrospective study of HLA antibody on kidney graft survival. Lee PC; Ozawa M; Hung CJ; Lin YJ; Chang SS; Chou TC Transplant Proc; 2009; 41(1):121-3. PubMed ID: 19249493 [TBL] [Abstract][Full Text] [Related]
30. Role of anti-IgG autoantibodies in kidney transplantation. Süsal C; Guo ZG; Terness P; Opelz G Immunol Lett; 1990 Nov; 26(2):121-5. PubMed ID: 2269482 [TBL] [Abstract][Full Text] [Related]
31. Does pretransplant soluble CD30 serum concentration affect deceased-donor kidney graft function 3 years after transplantation? Kovac J; Arnol M; Vidan-Jeras B; Bren AF; Kandus A Transplant Proc; 2008 Jun; 40(5):1357-61. PubMed ID: 18589105 [TBL] [Abstract][Full Text] [Related]
32. Pancreas transplant outcome with or without biological anti-T-cell therapy for induction immunosuppression with use of cyclosporine. Sutherland DE; Moudry-Munns KC; Gruessner A Transplant Proc; 1994 Oct; 26(5):2752-5. PubMed ID: 7940866 [No Abstract] [Full Text] [Related]
33. Transplant glomerulopathy: risk and prognosis related to anti-human leukocyte antigen class II antibody levels. Issa N; Cosio FG; Gloor JM; Sethi S; Dean PG; Moore SB; DeGoey S; Stegall MD Transplantation; 2008 Sep; 86(5):681-5. PubMed ID: 18791449 [TBL] [Abstract][Full Text] [Related]
34. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure. Cai J; Terasaki PI; Anderson N; Lachmann N; Schönemann C Transplantation; 2009 Jul; 88(2):226-30. PubMed ID: 19623018 [TBL] [Abstract][Full Text] [Related]
35. Improved cadaveric kidney graft survival with initiation of antilymphocyte globulin pretransplant in patients with a positive flow cytometry crossmatch. Hong JH; Sadeghian M; Sumrani N; Cacciarelli TV; Distant DA; Sommer BG; Norin AJ Transplant Proc; 1996 Jun; 28(3):1340-1. PubMed ID: 8658685 [No Abstract] [Full Text] [Related]
36. Do prophylactic antilymphocyte globulins (ALG and OKT3) improve renal transplant survival in recipient and donor high-risk groups? Cecka JM; Gjertson D; Terasaki PI Transplant Proc; 1993 Feb; 25(1 Pt 1):548-9. PubMed ID: 8438408 [No Abstract] [Full Text] [Related]
38. Kidney transplantation at extremes of age: CsA eliminates the increased risk in recipients < or = 5 or > or = 55 years. MacDonell RC; Van Buren DH; Richie RE; Johnson HK; Nylander WA; Helderman JH; Ynares CM; Trusler LA; Green WF; Crowe DA Transplant Proc; 1994 Oct; 26(5):2518-21. PubMed ID: 7940774 [No Abstract] [Full Text] [Related]
39. Effect of amino acid residue matching for HLA molecule in graft survival in renal transplantation. Ogahara S; Naito S; Noda R; Michinaga I; Murata T Transplant Proc; 1996 Jun; 28(3):1260-1. PubMed ID: 8658650 [No Abstract] [Full Text] [Related]
40. The fate of glomerular mesangial IgA deposition in the donated kidney after allograft transplantation. Ji S; Liu M; Chen J; Yin L; Sha G; Chen H; Liu Z; Li L Clin Transplant; 2004 Oct; 18(5):536-40. PubMed ID: 15344956 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]